Kankakee, IL, United States of America

Paul I Cook

USPTO Granted Patents = 8 


 

Average Co-Inventor Count = 5.6

ph-index = 4

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 1977-2022

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovations of Paul I Cook

Introduction

Paul I Cook is a notable inventor based in Kankakee, IL (US). He has made significant contributions to the field of biochemistry, particularly in the purification of alpha-1-antitrypsin (AAT). With a total of 8 patents to his name, Cook's work has had a substantial impact on pharmaceutical processes.

Latest Patents

One of Cook's latest patents involves a streamlined method for purifying alpha-1-antitrypsin from an AAT-containing protein mixture. This innovative method destabilizes contaminating proteins by cleaving disulfide bonds using a reducing reagent, such as dithiol, which does not affect AAT. The destabilized proteins are preferentially adsorbed onto a solid protein-adsorbing material without the need for additional salts as precipitants. This process results in a purified AAT solution that is suitable for chromatographic purification, eliminating the need for extensive desalting as required in previous methods. Furthermore, this process provides pharmaceutical-grade AAT in high yield on a commercial scale.

Career Highlights

Throughout his career, Paul I Cook has worked with prominent companies in the biopharmaceutical industry, including CSL Behring LLC and CSL Behring GmbH. His expertise in protein purification and treatment methods has positioned him as a valuable asset in the field.

Collaborations

Some of Cook's notable coworkers include Scott M Kee and James R Smith. Their collaborative efforts have contributed to advancements in the purification processes of therapeutic proteins.

Conclusion

Paul I Cook's innovative methods and contributions to the field of biochemistry highlight his importance as an inventor. His work continues to influence the pharmaceutical industry, particularly in the production of alpha-1-antitrypsin.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…